NDAORALTABLETPriority Review
Lifecycle
Pre-Launch
Clinical Trials
1
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Darunavir and ritonavir is an oral fixed-dose combination tablet containing two protease inhibitors used to treat HIV-1 infection. Darunavir is a protease inhibitor that blocks HIV protease enzyme, while ritonavir acts as a pharmacokinetic booster to increase darunavir levels. This combination is indicated for treatment-experienced and treatment-naïve HIV patients.
Pre-Launch
Early-stage product with undefined commercial trajectory; team structure and headcount requirements remain uncertain pending market launch.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women
Started Apr 2009
77 enrolled
HIVHIV InfectionsPregnancy
Career Relevance
This pre-launch product offers entry and growth opportunities for professionals building commercial infrastructure in HIV therapy. Career trajectory depends on successful market penetration and competitive differentiation in a crowded antiretroviral space.
Brand Manager
Worked on DARUNAVIR AND RITONAVIR at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.